Target intelligence / Profile preview

α2,3-linked sialic acid–containing cell-surface glycoproteins (α2,3-Sia)

Target
α2,3-Sia
Molecular classification
Glycoprotein, Glycan, Receptor
01

Overview

α2,3-linked sialic acid–containing cell-surface glycoproteins are complex molecules where a sialic acid (typically N-acetylneuraminic acid) is attached to a galactose residue via an α2,3-glycosidic bond. These glycoproteins are essential components of the glycocalyx and serve as critical mediators of cell-cell communication and host-pathogen interactions (Varki, A. Glycobiology. 2008;18(10):770-790). They are famously recognized as the primary attachment receptors for avian influenza viruses, such as H5N1 and H7N9, which utilize the viral hemagglutinin protein to bind these specific linkages (Shinya, K., et al. Nature. 2006;440(7083):435-436). In humans, these receptors are predominantly expressed in the lower respiratory tract and the conjunctiva, explaining the tissue tropism and severe pathology of avian-origin infections (Nicholls, J. M., et al. Lancet. 2007;370(9602):1841-1843). Beyond infectious disease, altered expression of α2,3-sialylated glycans is a hallmark of many cancers, where they contribute to tumor cell migration, invasion, and evasion of the immune response (Pearce, O. M., & Laubli, H. Cancer Res. 2016;76(11):3121-3126). Therapeutic interventions include the development of sialidases, such as DAS181, which enzymatically strip these sialic acids from the cell surface to prevent viral entry (Triana-Baltzer, G. B., et al. PLoS One. 2013;8(2):e56963).

Other names
Neu5Acα2-3GalAlpha-2,3-sialylglycansAvian influenza receptorα2,3-SASialyl-alpha2,3-galactose
02

Mechanism of action

Enzymatic removal of terminal sialic acid residues from the host cell surface to prevent viral hemagglutinin binding and entry; inhibition of viral neuraminidase to prevent the cleavage of these linkages during viral egress.

03

Biological functions

Viral attachmentCell-cell recognitionSignal transductionImmune modulationCell adhesion
04

Disease associations

InfectionInfluenzaCancerInflammation
05

Safety considerations

Potential disruption of endogenous sialic acid-dependent signalingMucosal irritationImmunogenicity of exogenous sialidase enzymesAlteration of complement system regulation
06

Interacting drugs

DAS181

3 more in the full profile.

07

Biomarkers

Maackia amurensis leukoagglutinin (MAL) bindingST3GAL expression levelsSialic acid density

Beyond the preview

Go deeper on α2,3-linked sialic acid–containing cell-surface glycoproteins (α2,3-Sia).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on α2,3-linked sialic acid–containing cell-surface glycoproteins (α2,3-Sia).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call